Effect of laparoscopic roux-en-y gastroenterostomy with BMI<35 kg/m 2 in type 2 diabetes mellitus

Obesity Surgery

Volumn 22, Issue 10, 2012, Pages 1562-1567

  Zhu, Liyong ^a   Mo, Zhaohui ^a   Yang, Xiangwu ^a   Liu, Shengping ^a   Wang, Guohui ^a   Li, Pengzhou ^a   Tan, Juan ^a   Ye, Fei ^a   Strain, Jeff ^b   Im, Ibrahim ^b   Zhu, Shaihong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Laparoscopic Roux en Y gastroenterostomy; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CHINA; CLINICAL ARTICLE; DIABETIC PATIENT; DIET RESTRICTION; DISEASE MARKER; FEMALE; FOLLOW UP; GASTROENTEROSTOMY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LAPAROSCOPIC ROUX EN Y GASTROENTEROSTOMY; LAPAROSCOPIC SURGERY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THERAPY EFFECT; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHINA; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 84866104878     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0694-0     Document Type: Article

References (25)

1. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515-29.
2. DeMaria EJ, Sugarman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640-5.
3. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339-52.
4. Buchwald H, Avidor Y, Braunwald E. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37.
5. 2: a report of 2 cases. Surg Obes Relat Dis. 2007;3:195-7.
6. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
7. DePaula AL, Macedo AL, Mota BR, et al. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc. 2009;23:1313.
8. Yang W, Juming Lu, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090-101.
9. He Y, Zhai F, Ma G, et al. Abdominal obesity and the prevalence of diabetes and intermediate hyperglycaemia in Chinese adults. Public Health Nutr. 2009;12:1078-84.
10. Rubino F, Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-9.
11. Ferzli GS, Dominique E, Ciaglia M, et al. Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg. 2009;33:972-9.
12. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg. 2009;19:1077-83.
13. Greenway S, Greenway F, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137:1109-17.
14. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes. Ann Surg. 2004;239:1-11.
15. Bose M, Oliva'n B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg. 2009;19:217.
16. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004;89:2608-15.
17. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008;31:S290-6.
18. Townsend CM, Beauchamp RD, Evers BM, et al. Sabiston textbook of surgery. 17th ed. Philadelphia: Saunders Elsevier; 2004. p. 363-82.
19. Pan CY, Jin WS. Prevalence of type 2 diabetes mellitus in China. Chin J Endocrinol Metab. 2005;21:491-5.
20. Alexander JW, Goodman HR, Hawver LR, et al. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis. 2009;5:237-41.
21. Sjostrom C, Lissner L, Wedel H, et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res. 1999;7:477-84.
22. Patel RA, Brolin RE, Gandhi A. Revisional operations for marginal ulcer after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5:317-22.
23. Dutta SK, Arora M, Kireet A, et al. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci. 2009;54:1243-6.
24. MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1:213-20.
25. Torquati A, Lutfi R, Abumrad N, et al. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg. 2005;9:1112-8.